325 related articles for article (PubMed ID: 32162389)
1. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
[TBL] [Abstract][Full Text] [Related]
2. Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation.
Balassa K; Salisbury R; Watson E; Lubowiecki M; Tseu B; Maouche N; Jeffery K; Misbah SA; Benamore R; Rowley L; Barton D; Pawson R; Danby R; Rocha V; Peniket A
J Infect; 2019 Jun; 78(6):461-467. PubMed ID: 30965067
[TBL] [Abstract][Full Text] [Related]
3. Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections.
Shah DP; Ghantoji SS; Ariza-Heredia EJ; Shah JN; El Taoum KK; Shah PK; Nesher L; Hosing C; Rondon G; Champlin RE; Chemaly RF
Blood; 2014 May; 123(21):3263-8. PubMed ID: 24700783
[TBL] [Abstract][Full Text] [Related]
4. Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation.
Egli A; Bucher C; Dumoulin A; Stern M; Buser A; Bubendorf L; Gregor M; Servida P; Sommer G; Bremerich J; Gratwohl A; Khanna N; Widmer AF; Battegay M; Tamm M; Hirsch HH; Halter JP
Infection; 2012 Dec; 40(6):677-84. PubMed ID: 22802096
[TBL] [Abstract][Full Text] [Related]
5. Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.
Foolad F; Aitken SL; Shigle TL; Prayag A; Ghantoji S; Ariza-Heredia E; Chemaly RF
Clin Infect Dis; 2019 May; 68(10):1641-1649. PubMed ID: 30202920
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.
Vakil E; Sheshadri A; Faiz SA; Shah DP; Zhu Y; Li L; Kmeid J; Azzi J; Balagani A; Bashoura L; Ariza-Heredia E; Chemaly RF
Transpl Infect Dis; 2018 Dec; 20(6):e12994. PubMed ID: 30195271
[TBL] [Abstract][Full Text] [Related]
7. A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study.
Piñana JL; Hernández-Boluda JC; Calabuig M; Ballester I; Marín M; Madrid S; Teruel A; Terol MJ; Navarro D; Solano C
Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28544152
[TBL] [Abstract][Full Text] [Related]
8. Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review.
Shah DP; Shah PK; Azzi JM; El Chaer F; Chemaly RF
Cancer Lett; 2016 Aug; 379(1):100-6. PubMed ID: 27260872
[TBL] [Abstract][Full Text] [Related]
9. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
[TBL] [Abstract][Full Text] [Related]
10. Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection.
Azzi JM; Kyvernitakis A; Shah DP; El Haddad L; Mahajan SN; Ghantoji SS; Heredia-Ariza E; Chemaly RF
J Antimicrob Chemother; 2018 Nov; 73(11):3162-3169. PubMed ID: 30113677
[TBL] [Abstract][Full Text] [Related]
11. Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.
Shah DP; Ghantoji SS; Shah JN; El Taoum KK; Jiang Y; Popat U; Hosing C; Rondon G; Tarrand JJ; Champlin RE; Chemaly RF
J Antimicrob Chemother; 2013 Aug; 68(8):1872-80. PubMed ID: 23572228
[TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus infections in children with cancer.
Chemaly RF; Ghantoji SS; Shah DP; Shah JN; El Taoum KK; Champlin RE; Nunez CA; Mulanovich V; Ariza-Heredia E
J Pediatr Hematol Oncol; 2014 Aug; 36(6):e376-81. PubMed ID: 24327130
[TBL] [Abstract][Full Text] [Related]
13. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative.
Beaird OE; Freifeld A; Ison MG; Lawrence SJ; Theodoropoulos N; Clark NM; Razonable RR; Alangaden G; Miller R; Smith J; Young JA; Hawkinson D; Pursell K; Kaul DR
Transpl Infect Dis; 2016 Apr; 18(2):210-5. PubMed ID: 26923867
[TBL] [Abstract][Full Text] [Related]
14. Comparing Human Metapneumovirus and Respiratory Syncytial Virus: Viral Co-Detections, Genotypes and Risk Factors for Severe Disease.
Moe N; Krokstad S; Stenseng IH; Christensen A; Skanke LH; Risnes KR; Nordbø SA; Døllner H
PLoS One; 2017; 12(1):e0170200. PubMed ID: 28095451
[TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients.
Houist AL; Bondeelle L; Salmona M; LeGoff J; de Latour RP; Rivière F; Soler C; Houdouin V; Dalle JH; Robin C; Fourati S; Griscelli F; Coman T; Chevret S; Bergeron A
Bone Marrow Transplant; 2021 Dec; 56(12):3032-3041. PubMed ID: 34548625
[TBL] [Abstract][Full Text] [Related]
17. Supplemental Oxygen-Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus.
Waghmare A; Xie H; Kimball L; Yi J; Özkök S; Leisenring W; Cheng GS; Englund JA; Watkins TR; Chien JW; Boeckh M
J Infect Dis; 2017 Dec; 216(10):1235-1244. PubMed ID: 28961971
[TBL] [Abstract][Full Text] [Related]
18. Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipients.
Gorcea CM; Tholouli E; Turner A; Saif M; Davies E; Battersby E; Dignan FL
J Hosp Infect; 2017 Feb; 95(2):214-217. PubMed ID: 28077243
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients.
Damlaj M; Bartoo G; Cartin-Ceba R; Gijima D; Alkhateeb HB; Merten J; Hashmi S; Litzow M; Gastineau D; Hogan W; Patnaik MM
Transpl Infect Dis; 2016 Apr; 18(2):216-26. PubMed ID: 26909896
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes.
Waghmare A; Campbell AP; Xie H; Seo S; Kuypers J; Leisenring W; Jerome KR; Englund JA; Boeckh M
Clin Infect Dis; 2013 Dec; 57(12):1731-41. PubMed ID: 24065324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
